|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/192 | (2006.01) |
| A61P 1/16 | (2006.01) |
| (11) | Number of the document | 3687523 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18811954.9 |
| Date of filing the European patent application | 2018-09-24 | |
| (97) | Date of publication of the European application | 2020-08-05 |
| (45) | Date of publication and mention of the grant of the patent | 2021-11-03 |
| (46) | Date of publication of the claims translation | 2022-03-25 |
| (86) | Number | PCT/US2018/052490 |
| Date | 2018-09-24 |
| (87) | Number | WO 2019/067373 |
| Date | 2019-04-04 |
| (30) | Number | Date | Country code |
| 201762563395 P | 2017-09-26 | US |
| (72) |
BOUDES, Pol , US
MCWHERTER, Charles, A. , US
STEINBERG, Alexandra, S. , US
|
| (73) |
CymaBay Therapeutics, Inc. ,
7575 Gateway Boulevard, Suite 110, Newark, CA 94560,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Cholestazinio niežulio gydymas seladelparu |
| TREATMENT OF CHOLESTATIC PRURITUS WITH SELADELPAR |
| Payment date | Validity (years) | Amount | |
| 2025-08-27 | 8 | 185.00 EUR |
| 2026-09-24 |